Emerging anti-cancer molecular mechanisms of aminobisphosphonatesMichele Caraglia, Alfredo Budillon|Endocrine Related Cancer|2006Cited by 131
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activationChiara Ciardiello, Alfredo Budillon|Journal of Experimental & Clinical Cancer Research|2019Cited by 125
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cellsMaria Rita Milone, Alfredo Budillon|Cell Death and Disease|2013Cited by 63
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathwaysFrancesca Bruzzese, Alfredo Budillon, Biagio Pucci et al.|Cell Death and Disease|2013Cited by 57
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylaseElena Di Gennaro, Alfredo Budillon, Francesca Bruzzese et al.|British Journal of Cancer|2010Cited by 49